Docoh
Loading...

Med-x

Filed: 4 Aug 19, 8:00pm

 

RICHARDSON
& ASSOCIATES

ATTORNEYS AT LAW

 

 

 

August 5, 2019

 

Via: EDGAR

 

United States

Securities and Exchange Commission

Division of Corporate Finance

Office of Healthcare & Insurance

100 F Street, N.E.

Washington, D.C. 20549

 

Attention:Jeffrey Gabor, Esq., Special Counsel

  

 

Re:Med-X, Inc.

 

 

Pre-Qualification Amendment Number Three to Offering Statement on Form 1-A

SEC File No. 024-11007

Originally filed on July 1, 2019                                                                                                         

 

Dear Mr. Gabor,

 

We respectfully request, as legal counsel on behalf of Med-X, Inc., that the above referenced Offering Statement on Form 1-A be declared qualified by the Securities and Exchange Commission, effective at 11:00 AM Eastern Daylight Time on Monday, August 12, 2019. The Financial Industry National Regulatory Authority (“FINRA”) has issued its no objection letter to Med-X, Inc.’s placement agent, NMS Capital Advisors, LLC, effective August 5, 2019.

 

 

Very Truly Yours,

   

/s/ Mark J. Richardson

 

Mark J. Richardson 
 

for

 
 Richardson & Associates 

 

 

 

cc:     Ronald Tchorzewski, Chief Financial Officer

 

 

Matthew Mills, President

 

 

 

1453 THIRD STREET PROMENADE, SUITE 315, SANTA MONICA, CALIFORNIA 90401

TELEPHONE (310) 393-9992 FACSIMILE (310) 393-2004